Abstract
We report a patient treated with botulinum toxin (BTX) for syringobulbia-induced cricopharyngeal dysphagia. A 54 year-old man with prior history of posttraumatic syringomyelia developed dysphagia suddenly. Bulbar function revealed palatal paresis and complete aglutition without lingual paresis. A videofluoroscopic swallowing study disclosed non-relaxation of the cricopharyngeal muscles (CPM). Follow-up magnetic resonance imaging displayed progression of syringobulbia and ascending syringomyelia. Symmetric slit-like medullary cavities could cause CPM dysfunction. A thoracic syringoperitoneal shunt had no therapeutic effects on dysphagia. He refused to undergo a syringocisternal shunt or cricopharyngeal myotomy. BTX (20 units) was injected into the left CPM under electromyographic guidance. Five days later, he was able to eat and drink gradually. Clinicoradiological profile of our patient indicated that the interruption of bilateral inhibitory projections from the solitary nuclei to the ambiguus nuclei could elicit uncontrollable CPM. BTX is beneficial and hopeful treatment for cricopharyngeal dysphasia due to progressive syringobulbia. doi:10.4021/jnr81w
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
